Abstract
Interstitial lung diseases represent a heterogeneous group of inflammatory and/or fibrosing diseases, which are primarily manifested in peripheral bronchioalveolar structures and lead to a mostly progressive impairment of pulmonary gas exchange and loss of lung volume. In addition to the basic clinical diagnostic procedures, making a diagnosis usually necessitates comprehensive lung function diagnostic tests, high-resolution thin layer computed tomography (native) of the lungs and a transbronchial lung (cryo)biopsy. Depending on the underlying disease and the dominant pathogenesis, immunomodulatory drugs or antifibrotic drugs are used for treatment. Progressive fibrosing interstitial lung disease (PF-ILD) is now newly described as a uniform phenotype, which benefits from an antifibrotic treatment, independent of the original underlying disease.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 1613-5636 |
Sprache: | Deutsch |
Dokumenten ID: | 96901 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:24 |
Letzte Änderungen: | 17. Okt. 2023, 14:53 |